Media
Press Releases
May 7, 2025
Lupin Launches Eslicarbazepine Acetate Tablets in the United States
April 24, 2025
Lupin Receives Approval from U.S. FDA for Tolvaptan Tablets
March 20, 2025
Lupin Awarded EcoVadis Silver Medal for Sustainability Excellence, Ranks Among the Top 15% Globally
March 17, 2025
Lupin Receives Tentative Approval from U.S. FDA for Amifampridine Tablets
March 7, 2025
Lupin Launches Rivaroxaban Tablets USP, 2.5mg in the United States
February 27, 2025
Lupin Secures a Place in the Prestigious S&P Global Sustainability Yearbook 2025
February 21, 2025
Lupin Receives EIR from U.S. FDA for its Somerset Manufacturing Facility
February 19, 2025
Lupin Receives “A-” Leadership Rating from CDP in Two Categories – Climate Change and Water Security
February 10, 2025
Lupin and Natco Receive Approval from U.S. FDA for Bosentan Tablets for Oral Suspension
Media
Rajalakshmi Azariah
Vice President & Global Head - Corporate Communications
rajalakshmiazariah@lupin.comElise Titan
Director, U.S. Communications
elisetitan@lupin.comSmart Guide
Close
CloseSearch Product